1. GPCR/G Protein MAPK/ERK Pathway Apoptosis Cell Cycle/DNA Damage Epigenetics
  2. Ras Apoptosis PARP Caspase CDK
  3. MRTX849-amide-C4-(o)-carborane

MRTX849-amide-C4-(o)-carborane is a KRASG12C inhibitor with mutation selectivity for cells expressing KRASG12C. MRTX849-amide-C4-(o)-carborane shows low intrinsic cytotoxicity in cancer cells. MRTX849-amide-C4-(o)-carborane covalently binds to Cys12 of KRASG12C, recruits Hsp70, promotes ubiquitination, and induces proteasome-dependent degradation of the target protein. MRTX849-amide-C4-(o)-carborane inhibits the activity of the downstream ERK signaling pathway and induces apoptosis signaling in cancer cells. MRTX849-amide-C4-(o)-carborane is applicable for the research of KRASG12C-positive cancers.

For research use only. We do not sell to patients.

MRTX849-amide-C4-(o)-carborane

MRTX849-amide-C4-(o)-carborane Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

MRTX849-amide-C4-(o)-carborane is a KRASG12C inhibitor with mutation selectivity for cells expressing KRASG12C. MRTX849-amide-C4-(o)-carborane shows low intrinsic cytotoxicity in cancer cells. MRTX849-amide-C4-(o)-carborane covalently binds to Cys12 of KRASG12C, recruits Hsp70, promotes ubiquitination, and induces proteasome-dependent degradation of the target protein. MRTX849-amide-C4-(o)-carborane inhibits the activity of the downstream ERK signaling pathway and induces apoptosis signaling in cancer cells. MRTX849-amide-C4-(o)-carborane is applicable for the research of KRASG12C-positive cancers[1].

IC50 & Target

KRAS(G12C)

 

Cdk4/cyclin D1

 

Caspase-3

 

In Vitro

HY8 (up to 50 μM; 72 h) shows no cytotoxicity at concentrations up to 50 μM in NCI-H23, MIA Paca-2, and HCT116 cells after 72 h of treatment, with an IC50 >50 μM in all lines[1].
HY8 (50 μM; 8 h, following 2 h pre-incubation with 5 μM MRTX849) covalently binds to the same Cys12 site on KRASG12C as MRTX849 in NCI-H23 cells, as pre-treatment with MRTX849 blocks HY8-induced KRASG12C degradation[1].
HY8 (50 μM; 8 h, co-incubated with MG132) induces degradation of KRASG12C in NCI-H23 cells that is dependent on the proteasome pathway, as co-treatment with MG132 abrogates degradation[1].
HY8 (10-50 μM; 8 h) activates pro-apoptotic signaling in NCI-H23 cells in vitro in a dose-dependent manner after 8 h treatment with 10, 30, or 50 μM, as shown by cleavage of PARP and caspase 3, and reduced CDK4 and cyclin D1 levels[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: NCI-H23 (KRASG12C-positive)
Concentration: 10-50 μM
Incubation Time: 24 h
Result: Induced dose-dependent degradation of KRASG12C and concurrent reduction in phosphorylated ERK (p-ERK) levels, with maximal effects observed at 50 μM.

Western Blot Analysis[1]

Cell Line: NCI-H23 (KRASG12C-positive)
Concentration: 10 μM, 30 μM, 50 μM
Incubation Time: 8 h
Result: Induced dose-dependent cleavage of PARP and caspase 3, and reduced levels of CDK4, indicating activation of apoptotic signaling.
Molecular Weight

816.42

Formula

C38H51B10ClFN7O3

SMILES

ClC1=CC=CC2=C1C(N(C3)CCC(C3=NC(OC[C@@H]4N(C(CCCCC5678[BH]9%10%11[BH]%12%13([BH]%10%14%15[BH]8%11%16[BH]%17%15%18%19)[BH]%20%14%18[BH]%21%22%17[CH]5%16%19[BH]%216%23[BH]9%127[BH]%20%13%22%23)=O)CCC4)=N%24)=C%24N%25C[C@H](CC#N)N(C(C(F)=C)=O)CC%25)=CC=C2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
MRTX849-amide-C4-(o)-carborane
Cat. No.:
HY-182044
Quantity:
MCE Japan Authorized Agent: